Strive (ex-Asset Entities)

Phase A — Understand the business

Lens 1 · Company Overview

The plain-terms model. Strive raises capital (common equity + a 13% perpetual preferred called SATA) and uses it to buy and hold bitcoin, aiming to grow bitcoin-per-share faster than it dilutes. Legally it is now Strive, Inc. (Nevada; HQ 200 Crescent Ct., Dallas TX; Commission file 001-41612), the renamed successor of Asset Entities Inc.. It calls itself "the first U.S. publicly traded bitcoin treasury asset management firm".

How it came to exist (three stacked transactions in ~6 months):

1. Alpha Merger (the reverse merger) — Strive Enterprises, Inc. (Ohio; Vivek Ramaswamy's asset manager) merged into a subsidiary of Asset Entities; on 12 Sep 2025 Asset Entities was renamed Strive, Inc.. This is what made Strive public.
2. PIPE + 351 Exchange (the BTC war chest) — concurrent with closing, Strive raised $749.6M gross in a PIPE (Class A + pre-funded warrants) with the ability to raise $749.6M more on warrant exercise; separately swapped 2.7M shares (134k split-adjusted) for 69 BTC in a Section-351 exchange, and open-market bought 7,558 BTC — so it entered public life already holding bitcoin. PIPE priced at $1.35/share, a 121% premium to the pre-announcement close.
3. Semler Scientific Merger — announced 22 Sep 2025, closed 16 Jan 2026, all-stock; Strive absorbed Semler's medical-device business (the QuantaFlo PAD test), its ~5,000 BTC, and its 4.25% convertible notes.

Three revenue lines, two of them tiny. Q1 2026 total revenue was just $2.76M:

• Investment advisory fees $1.35M (Strive Asset Management — the anti-ESG ETFs + actively managed fixed income; >$2.4B AUM at 12/31/25, ~$2.7B by mid-2026 ).
• Medical device revenue $1.37M (QuantaFlo, inherited from Semler).
• Other $0.04M.

The operating businesses are rounding error next to the ~$929M–$1.5B BTC book. Customers/counterparties that matter: Coinbase (custody + the exchange whose spot marks the book, a Level-1 input); SATA preferred holders (the funding base); Medicare-Advantage insurers, esp. UnitedHealth, as QuantaFlo end-users. Contract structure: advisory fees are recurring/AUM-linked; there is no take-or-pay; the "recurring" cash the model actually depends on is the outbound SATA dividend, not inbound revenue.

Lens 2 · Supply Chain

For a treasury vehicle the "supply chain" is the capital-in → BTC → NAV → capital-out loop and its named counterparties:

• Capital sources (upstream): PIPE investors ($749.6M) and Section-351 accredited investors; the SATA ATM ($487.8M remaining capacity at 3/31/26) and the Class A common ATM ($276.3M remaining); and inherited Semler 4.25% convertibles (all since repurchased — zero debt by 12 May 2026).
• Asset acquisition (midstream): bitcoin bought on the open market and via the 351 swap; acquisitions of $521.3M of BTC in Q1 2026 alone (aggregate cost basis $1,225.2M). Distinctive "alpha" sourcing: Mt. Gox distressed BTC claims via a partnership with 117 Partners LLC (targeting up to ~75,000 BTC of claims) and buying structured BTC credit — e.g. $50M of MSTR's STRC/"Stretch" preferred.
• Custody / pricing (chokepoint): Coinbase is the custodian and the exchange whose quoted price marks the entire book to fair value each period (ASC 350-60 / ASC 820, Level 1). A prior Coinbase Loan (BTC-collateralized) was extinguished for $20.3M in Q1.
• End "customer" (downstream): the public equity and SATA markets — the vehicle only works if buyers pay ≥ NAV for the shares and ~$100 for SATA.

Single-source dependencies: BTC itself (one asset, no diversification), Coinbase (custody + price feed), and the SATA bid (the funding lifeline). Names present — this is not a generic map.

Lens 3 · Competitive Advantages (moats)

Be blunt: a pile of bitcoin has no moat. Anyone — including a spot BTC ETF (IBIT, FBTC) at ~0.25% fees with zero NAV premium and no dividend drag — can offer the same beta more cheaply. Strive's claimed differentiators:

1. The "alpha" overlay — the one arguably real edge. Buying BTC below spot (Mt. Gox claims at a discount, cash-rich companies below liquidation value like Semler, discounted structured credit) can grow BTC-per-share faster than buy-at-market rivals. Semler was accretive on paper: Strive booked a $66.7M bargain-purchase gain (net assets acquired > consideration). But this is unproven and lumpy — the Mt. Gox claims haven't closed, and each deal is bespoke, not a repeatable machine.
2. The SATA capital structure — a variable-rate perpetual preferred that (Strive argues) lets it raise BTC-buying capital without diluting common the way an ATM does, and the first U.S. security to pay a daily cash dividend. Structurally elegant; economically it is permanent 13% carry the common must cover.
3. The anti-ESG asset-management brand — Ramaswamy's "pro-shareholder/anti-woke" ETF franchise ($2.7B AUM) gives a distribution surface and a recurring (if breakeven) fee stream. This is the only piece with genuine switching costs, and it is small.

Bargaining power: essentially none over BTC (price-taker) or Coinbase (custody-taker). Over capital it has some — the SATA bid has been strong enough to fund buys — but that power inverts the moment mNAV < 1, because then issuing equity/preferred to buy BTC destroys per-share value. Verdict on moat: the durable moat is ~$2.7B of sticky-ish AUM; the BTC book is a commodity with negative structural carry.

Lens 4 · Segments

segments.csv is empty in the research layer, so all figures are pulled directly from the filing income statement:

Geography: not broken out in the filing; operations are U.S.-centric (Dallas TX + Dublin OH offices). The trend that matters is not in this table. The economically dominant "segment" is the investment-gains line: a −$295.8M unrealized loss on digital assets in Q1 2026 swamps the entire $2.76M revenue base by ~100x. Reading Strive as a three-segment operating company is a category error — it is a BTC book with a fee-business garnish. Management itself guides the asset-management segment to a single-digit-$M operating loss-to-profit range for FY2026 — i.e. explicitly not a profit engine.

---

Phase B — Measure performance

Lens 5 · Earnings Result (Q1 2026, the first "real" combined quarter)

All figures:

• Total revenue $2.76M (+94% YoY, all Semler). Meaningless to the thesis.
• Total operating expenses $20.6M (+275% YoY) — driven by $13.1M employee comp (incl. $6.5M SBC, some from assumed Semler options) and $5.9M G&A (public-company + deal costs). The operating cost base alone is ~7.5x revenue.
• Net unrealized loss on BTC: −$295.8M — the quarter's defining number. BTC fell from a weighted-avg acquisition cost of $104,174 toward a $68,198 period-end mark.
• Net operating loss −$313.1M.
• Below the line: a $66.7M bargain-purchase gain (Semler), −$8.5M loss on debt extinguishment, −$6.5M transaction costs, −$2.6M Coinbase-collateral mark = +$47.2M total other income.
• Net loss −$265.9M; after −$13.5M preferred dividends, net loss to common −$279.4M, or −$4.53/share (basic = diluted; 61.6M wtd-avg shares).
• Non-GAAP adjusted net loss −$306.2M (strips SBC, D&A, extinguishment, transaction costs, and the bargain-purchase gain) → −$5.19/share adjusted. Note the honesty cuts both ways: excluding the $66.7M gain makes adjusted worse than GAAP.

Balance sheet (3/31/26): total assets $1,100.3M, of which digital assets $929.4M; cash $95.1M; STRC preferred investment $50.5M; intangibles $15.0M. Total liabilities just $26.3M (near-zero debt). Mezzanine SATA preferred $359.2M carrying value ($437.3M redemption/liquidation value, 4,373,194 shares). Common equity: 59.3M Class A + 9.9M Class B. Total stockholders' equity $714.8M; accumulated deficit −$753.4M.

Cash flows: operating −$31.0M (real cash burn before any BTC buys); investing −$123.8M (BTC −$77.3M + STRC −$50.5M); financing +$182.4M (SATA +$129.8M, common +$95.0M, less dividends −$10.9M, costs −$10.8M, Coinbase-loan payoff −$20.3M).

vs. consensus / market reaction: DATs at this stage have negligible sell-side EPS consensus, so a "beat/miss" frame is n/a. The tape is the verdict: ASST −87.9% over the trailing year, −37.4% over the past month, −22.8% YTD. The market has re-rated the whole DAT complex from premium to discount, and Strive harder than most.

Unusual vs. its own history: everything — there is no pre-2025 history as a BTC vehicle (first BTC held 12 Sep 2025). The one thing to flag: management declared disclosure controls "effective" and reported no material weakness, which for a company that stitched together a reverse merger + a public-co acquisition + a novel preferred in two quarters is worth watching but not (yet) a red flag.

Lens 6 · Earnings Calls (sentiment trend)

No transcripts on the shelf (transcripts/ empty; the reverse-merged entity has essentially one reporting cycle of history). From filings + the primary-source press releases, management's messaging is relentlessly on-message and accumulation-first. The three stated objectives, verbatim: (i) accumulate bitcoin; (ii) increase bitcoin-per-share; (iii) outperform bitcoin over the long run via "beta" accumulation + "alpha" strategies.

Tone shift over the two available quarters: the emphasis has visibly rotated from "grow the stack" toward "engineer the SATA yield." Q1 close and the May–June cadence lean heavily on financial-engineering signals — retiring all debt (zero leverage, no encumbered BTC), launching daily SATA dividends (≈13.88% effective APY), raising the SATA rate 12.75%→13.00%, and a public letter to MSCI protesting reclassification of DAT firms as "funds". The phrases that recur: "bitcoin-per-share," "no margin requirements," "dual-reserve." What is conspicuously quieter than at launch: the "$7.9B Mt. Gox claims / 75,000 BTC" alpha story that dominated the 2025 pitch — a tell that the differentiated leg has not yet delivered. Sentiment read: defensive-confident — projecting strength on the capital structure precisely because the equity is under NAV.

Lens 7 · Comps (the DAT peer set — the only comp that matters is mNAV)

The relevant peer group is other bitcoin-treasury companies, compared on mNAV (market cap ÷ BTC-NAV), not P/E. Traditional multiples are largely meaningless for pre-earnings BTC shells.

Peer P/E, EV/Sales, EV/EBIT, dividend yield, 5yr ROE for Strive: n/a / not meaningful (no positive earnings; revenue $2.76M/qtr; "dividend yield" is on the preferred, not common).

What the table says: one in three of ~156 public BTC treasuries now trade below 1.0x mNAV, and one in four below their BTC value outright. Strive is firmly in the discounted cohort — cheaper on mNAV than MSTR and Metaplanet, roughly in line with the sub-scale names (SWC, ACPB, NAKA). The bull reads "0.72x = buy $1 of BTC for 72¢." The bear reads "0.72x = the market prices in dilution, the 13% preferred drag, and doubt the alpha closes." Both are looking at the same number.

Lens 8 · Stock-Price Catalysts

ASST has <1 year of history as Strive, so "5-year >5% moves" compresses into a violent 10-month arc:

• May 2025 — $750M PIPE announced at a 121% premium; the shell rips (this is the "liftoff").
• Oct 2025 — surges on the anti-woke/BTC narrative, then sells off on a filing to register ~1.3B new shares (dilution panic).
• Jan 2026 — Semler merger closes; BTC/medical-device consolidation begins.
• Mar–May 2026 — SATA machine ramps: $50M into MSTR's STRC, SATA rate hikes, daily-dividend launch.
• H1 2026 grind — the dominant driver becomes BTC's own decline to a 652-day low (~$58–63K) amplified by DAT-premium compression → −87.9% trailing year.

What the market actually reacts to: (1) the BTC price (Strive is a ~1x-to-levered proxy), (2) share/preferred issuance (dilution fear), and (3) capital-structure headlines (SATA yield, debt payoff). Notably not the operating segments. The pattern confirms this is traded as a bitcoin-plus-financing instrument, full stop.

---

Phase C — Judge people & books

Lens 9 · Management

The archetype: founder-sponsor + hired institutional operator. insider-transactions.csv is not on the shelf; ownership facts are from the 10-K.

• Vivek Ramaswamy — founder & controlling shareholder (not an officer). Founded Strive Asset Management in 2022 (with ex-Anheuser-Busch president Anson Frericks). Via a Shareholders' Agreement he and allied holders control >50% of the voting power → Strive is a Nasdaq "controlled company" and can skip certain governance requirements. Track record: built Roivant-adjacent biotech wealth, a fast-scaling ETF brand, and national political profile; left day-to-day to run for office / DOGE. Implication: the brand and capital-raising gravity are his; the accountability is diffuse (a controlled company with the visionary off-stage).
• Matthew Cole (41) — CEO & Chairman of the Board. Ex-CalPERS, ~15 years, oversaw >$70B in actively managed fixed income; CFA; joined Strive AM May 2022 as Head of Investment Office, promoted to CIO, then CEO. Genuinely credible institutional-markets operator — which matters, because the SATA/structured-credit engine is a fixed-income-desk product, and that is exactly Cole's background.
• Other officers/directors: Benjamin Pham (32, CFO & Director), Brian Logan Beirne (44, CLO & Director), Arshia Sarkhani (29, CMO & Director) — a strikingly young exec bench; Pierre Rochard (36, Director — a well-known bitcoin figure/maximalist, signals credibility to the crypto base); Shirish Jajodia; Eric Semler (61, Director — former Semler chairman, the bridge from that deal); James A. Lavish (a known BTC-fund manager).
• Capital-allocation history (10 months): raised ~$750M+ PIPE + ongoing ATMs; converted it into ~19,000 BTC at a blended cost that started ~$104K (Q1) and, with lower buys since, is reported ~$75–78K; retired all debt; initiated a 13% perpetual preferred. On paper Semler was value-accretive ($66.7M bargain gain). But the scoreboard is brutal: they bought a falling asset with expensive-to-service capital and the common is −88%. ROE/ROIC are deeply negative and not a useful gauge this early.
• Red flags to weigh: controlled-company governance; very high SBC ($6.5M in one quarter on $2.76M revenue); a novel, aggressively marketed preferred whose 13% cost is a permanent claim ahead of common; promotional posture (MSCI letters, "first daily dividend" PR). None is fraud; collectively they say "financial-engineering shop, shareholder-value-of-common is subordinate to growing the stack and defending SATA."

Lens 10 · Forensic Red Flags

Forensic lens on a fair-value BTC book + a two-merger accounting stack.

1. Fair-value BTC swamps everything. Under ASC 350-60 the entire $929M book is marked to Coinbase spot each period; a −$295.8M swing hit the P&L in one quarter. Earnings are the BTC price. Not a "flag" (it's the correct new accounting) but it makes GAAP net income almost pure BTC beta with no analytical content.
2. The bargain-purchase gain (+$66.7M). A bargain-purchase gain (buying net assets for less than fair value) is legitimate but inherently judgmental — it depends entirely on the fair values Strive assigned to Semler's acquired assets/liabilities. It flatters GAAP net loss by $66.7M and management correctly strips it from non-GAAP. Watch for any purchase-accounting true-ups in the 10-K/next 10-Q.
3. Cash flow vs. earnings divergence — the important one. GAAP net loss −$265.9M is dominated by a non-cash −$295.8M mark; but operating cash burn is a real −$31.0M/quarter, funded entirely by financing (issuing SATA/common). The company is cash-flow-negative before it buys a single satoshi, and the dividend is cash out the door. That is the structural fragility, and it is not hidden — it's in the cash-flow statement.
4. SBC flattering the operating story. $6.5M SBC is ~50% of the $13.1M comp line and ~2.4x total revenue; a chunk is assumed Semler options. Standard for the sector, but it dilutes and it is real economic cost.
5. Preferred classified in mezzanine, not equity or debt. SATA sits in mezzanine equity ($359.2M carrying / $437.3M redemption value) — neither common equity nor a debt liability, so simple debt/equity screens understate the senior claim ahead of common. An analyst must treat SATA's $437.3M liquidation preference + its ~13% dividend as a quasi-debt claim.
6. Emerging-growth-company reduced disclosure — Strive elects JOBS-Act EGC accommodations (reduced disclosure), so expect less granularity than a seasoned filer.

Regulatory findings (required sub-section):

• SEC Litigation Releases / AAERs: None naming Strive/Asset Entities in 2021-07-06 → 2026-07-06.
• 10-K/10-Q Item 3 (Legal Proceedings): Strive itself reports ordinary-course litigation only, "no material adverse effect" expected. BUT the inherited Semler exposure is material: Ravi Krishnamoorthy v. Semler Scientific, et al. (N.D. Cal., filed 29 Aug 2025) — a putative securities class action (§10(b)/§20(a)) over the timing/extent of Semler's disclosure of the DOJ QuantaFlo matter.
• Non-SEC enforcement (web): Semler Scientific — which Strive now owns — agreed in Sep 2025 to pay ~$29.75M to settle DOJ False Claims Act allegations that its QuantaFlo PAD test was marketed for Medicare billing that didn't meet requirements (combined ~$36.95M with Bard). A significant QuantaFlo customer (~half of Semler's Q2'25 revenue) began rolling back use from Oct 2025. This is inherited legal + revenue-impairment risk on the medical-device leg, though small relative to the BTC book.
• Summary: No enforcement action against Strive/Asset Entities itself. Material inherited exposure via Semler (DOJ FCA settlement + related securities class action). Verified via SEC EDGAR EFTS (LR, AAER), 10-Q Item 1, and web search as of 2026-07-06.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection

GAAP EPS is un-forecastable here — it is a function of the unknowable future BTC price (a −$296M swing on a ~$60K→$68K move in one quarter). Forecasting "FY-EPS" for a BTC book would be false precision. n/a / not meaningful. No forecast.ts EPS forecast is logged (correct for a treasury vehicle; and this is a --watchlist run where the skill says skip the create step).

The right projection is BTC-per-share and mNAV under BTC-price scenarios. Anchors: ~19,000 BTC; ~69.3M Class A + 9.9M Class B ≈ 79.2M common shares; SATA senior claim ≈ $437M liquidation pref + ~13%/yr ≈ ~$57M/yr dividend; ~$95M cash. Current mkt cap ≈ $832M.

BTC-NAV-per-common estimate:

• Gross BTC value = 19,000 × BTC price.
• Less senior SATA liquidation preference ~$437M; plus ~$95M cash + ~$50M STRC ≈ net non-BTC roughly −$290M.
• Net-to-common ÷ 79.2M shares.

The load-bearing insight: at spot, ASST is roughly at NAV by this conservative (senior-claim-adjusted) math — the "0.72x mNAV" screens ignore the $437M preferred sitting ahead of common. Adjust for the preferred and the "cheap to NAV" story shrinks materially. The three levers that decide the next year: (1) BTC direction, (2) whether they can stop diluting/issuing SATA under 1.0x mNAV, (3) whether the Mt. Gox "alpha" actually lands BTC below cost. Brier forecast to log later (not in this loop): "ASST trades ≥ 1.0x reported mNAV at any point in FY2026: p ≈ 0.45".

Lens 12 · Bull vs Bear

Bull case. You are buying ~$1.2–1.5B of bitcoin for an ~$830M market cap — leveraged BTC beta at a discount, with a credible institutional operator (Cole) running a differentiated accumulation engine: distressed Mt. Gox claims and cash-rich takeouts (Semler) that grow BTC-per-share faster than spot, plus a self-funding 13% perpetual preferred that raises BTC-buying capital without common dilution and now pays daily. Zero debt, no encumbered BTC, no margin calls. If BTC re-rates and the DAT-premium returns to >1.0x, the equity is a double-levered call (BTC up + multiple re-expands), and the ~$2.7B anti-ESG AUM franchise provides a real, recurring floor and distribution moat. Ramaswamy's political/brand gravity keeps the capital tap open.

Bear case. This is a closed-end fund that trades at a discount and is structurally short its own stock. Three things that can permanently impair it: (1) The accretion flywheel is inverted. DATs only create value by issuing equity above NAV to buy BTC; below 1.0x mNAV, every issuance is value-destructive to common — so the model's core engine is currently anti-accretive, and management's own reticence (SMLR-style pause) confirms it. (2) The 13% SATA is a permanent, senior, cash claim (~$57M/yr) on a NAV that shrinks with BTC — a classic negative-carry / "spiral of doom" setup: if BTC falls, NAV compresses, the preferred's effective burden rises, common gets crushed, and the equity tap (needed to service everything) closes exactly when it's needed. (3) BTC itself at a 652-day low with the whole DAT complex de-rated — Strive is a high-beta expression of a broken trade. Pre-mortem (18 months out, thesis broke): BTC drifted $50–60K, ASST sat at 0.6x mNAV for a year, SATA had to yield 14–15% (or slid well below par) to keep raising, the Mt. Gox "alpha" never closed or closed small, dilution ground BTC-per-share down, and the stock is a sub-$5 melting ice cube while the preferred consumes the cash. Are multiples too high? On mNAV, no — it's cheap. On "is the business model viable below 1.0x mNAV," the honest answer is the model doesn't work below par, which is where it lives. Contrarian view the market may be missing (cuts bullish): the discount could be an over-correction if the alpha overlay is real — a cash-rich-takeout machine run by a fixed-income pro is genuinely not the same instrument as a buy-at-any-price MSTR clone, and at 0.7x you are paid to wait. The market is pricing Strive as "just another sub-scale DAT" and may be under-weighting the one leg (Cole + distressed sourcing) that could differentiate it.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull. Where the money is made structurally breaks below par — and it's below par. The bull's entire engine (issue stock > NAV → buy BTC → BTC-per-share rises → premium justified → issue more) runs in reverse at 0.72x: issuing here dilutes BTC-per-share, so the flagship KPI actively deteriorates every time they raise. Revenue concentration? Irrelevant — there is barely any revenue; the "concentration" is 100% in a single volatile asset (BTC) marked on a single venue (Coinbase). The moat is weaker than bulls think because a spot ETF delivers the same BTC beta at 0.25% with no NAV discount, no 13% preferred drag, and no dilution risk — Strive has to beat BTC by enough to overcome ~13% senior carry + dilution just to tie the ETF. Most dangerous competitor bulls underestimate: not MSTR — it's IBIT/FBTC (the ETFs) and the DAT-arbitrage funds that will short the equity toward NAV whenever it pops. Worst capital-allocation risk: the SATA preferred itself — marketing a 13% daily-dividend "return-of-capital" yield to raise money to buy a falling asset is exactly the sort of structure that looks brilliant in a bull market and becomes a death-spiral anchor in a bear one; if SATA slips well below its $99–101 target range, the funding cost to defend it (raise the rate) climbs precisely as ability to pay falls. Assumptions that must hold for today's ~$11 price: BTC doesn't keep falling; the equity/SATA markets stay open; the Mt. Gox alpha delivers; and no purchase-accounting or Semler-litigation surprise. Growth disappoints 20–30% (BTC falls another ~25% to ~$47K): by the Lens-11 table NAV/common drops toward ~$7 and the stock would likely trade below that on a widened discount and dividend-drag fear — i.e. materially lower. Single scenario that permanently impairs: a prolonged BTC bear (12–24 months sub-$55K) forces continuous below-NAV issuance to fund the SATA dividend, mechanically shrinking BTC-per-share until the vehicle is a permanent sub-0.6x discount with no path to re-rate — the closed-end-fund trap, made worse by a senior preferred. Plausibility: moderate and rising given the 652-day BTC low.

Lens 14 · Management Questions (ordered by information value)

1. Below 1.0x mNAV, issuing common or SATA to buy BTC is dilutive to bitcoin-per-share. What is your explicit mNAV threshold below which you stop issuing — and are you at it now?
2. The SATA dividend is ~$57M/yr and senior to common. Walk through how it is funded in a 12-month BTC bear where the equity/preferred windows are shut — how many months of dividend can you cover from cash + advisory fees without issuing?
3. The Mt. Gox / distressed-claims "alpha" was the 2025 differentiator. How much BTC have you actually acquired below spot via claims to date, at what discount, and what is the realistic timeline to the ~75,000-BTC opportunity?
4. If SATA trades persistently below its $99–101 target, how high are you willing to push the dividend rate to defend par, and at what rate does the structure stop making sense?
5. Bitcoin-per-share is your stated KPI. What is it today, and did it rise or fall over the last two quarters net of all issuance and the preferred?
6. What is your response to the argument that a spot BTC ETF gives investors the same beta at 0.25% fees with no discount, no preferred drag, and no dilution — what must Strive deliver annually to beat that hurdle?
7. You are a Nasdaq controlled company with Vivek Ramaswamy holding >50% voting power while off-stage politically. How are minority-common holders protected, and what related-party guardrails exist?
8. Semler brought a DOJ FCA settlement and a securities class action. What residual QuantaFlo revenue and legal exposure did you underwrite, and would you divest the medical-device business?
9. You retired all debt but chose a 13% perpetual preferred over convertibles. Why is permanent 13% carry superior to a lower-coupon convert for shareholders of the common?
10. The bargain-purchase gain was $66.7M. What were the key fair-value assumptions, and what true-up risk remains?
11. AUM is ~$2.7B at roughly breakeven. Is the asset-management business strategic, or is it a distribution wrapper for the BTC treasury — and would you ever sell it?
12. Under what circumstances would you sell bitcoin — is there any NAV-discount or liquidity trigger, or is it hold-only?
13. What is your custody-concentration plan given Coinbase is both custodian and your fair-value price source?
14. What return-of-capital or buyback framework applies to the common if the discount to NAV persists past, say, 12 months?
15. Three years out, what does success look like in one number — BTC count, bitcoin-per-share, mNAV, or something else — and what is the single biggest risk to it?

---